Endocrinology and Metabolism

The Korean Endocrine Society (대한내분비학회)
권호 표지

Inflammation and Obesity

염증과 비만

Park, Cheol-Young;Yoo, Hyung-Joon
박철영;유형준

  • Published : 20040000
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Nathan C: Points of control in inflammation. Nature 420(6917):846-52, 2002 https://doi.org/10.1038/nature01320
  2. Tracey KJ: The inflammatory reflex. Nature 420(6917):853-9, 2002 https://doi.org/10.1038/nature01321
  3. Libby P: Inflammation in atherosclerosis. Nature 420(6917):868-74, 2002 https://doi.org/10.1038/nature01323
  4. Das UN: Is obesity an inflammatory condition? Nutrition 17(11-2):953-66, 2001
  5. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA 282(22):2131-5, 1999
  6. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Low-grade systemic inflammation in overweight children. Pediatrics 107(1):E13, 2001
  7. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330(6149):662-4, 1987 https://doi.org/10.1038/330662a0
  8. Lyon CJ, Law RE, Hsueh WA: Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144(6):2195-200, 2003
  9. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: West of Scotland Coronary Prevention Study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51(5):1596-600, 2002
  10. Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, Shepherd J, Gaw A: Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103(3): 357-62, 2001
  11. Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B: HOPE Study Investigators. Ramipril and the development of diabetes. JAMA 286(15):1882-5, 2001
  12. Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S: For the LIFE study group. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens 20(9):1879-86, 2002
  13. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP: C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149:139-50, 2000
  14. Szalai AJ, van Ginkel FW, Dalrymple SA, Murray R, McGhee JR, Volanakis JE: Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 160(11):5294-9, 1998
  15. Tsukui S, Kanda T, Nara M, Nishino M, Kondo T, Kobayashi I: Moderate-intensity regular exercise decreases serum tumor necrosis factor-alpha and HbA1c levels in healthy women. Int J Obes Relat Metab Disord Sep; 24(9):1207-11, 2000 https://doi.org/10.1038/sj.ijo.0801373
  16. Wellen KE, Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112(12):1785-8, 2003
  17. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature 420(6913):333-6, 2002 https://doi.org/10.1038/nature01137
  18. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factoralpha: direct role in obesity-linked insulin resistance. Science 259(5091):87-91, 1993 https://doi.org/10.1126/science.7678183
  19. Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, Penicaud L, Casteilla L: Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 14;278(11):9850-5, 2003
  20. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J Clin Invest 112(12): 1821-30, 2003
  21. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796-808, 2003
  22. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M: Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun Jan 17;300(3):674-8, 2003 https://doi.org/10.1016/S0006-291X(02)02864-4
  23. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103(8):1057-63, 2001
  24. O'Rourke L, Gronning LM, Yeaman SJ, Shepherd PR: Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J Biol Chem 277(45): 42557-62. Epub 2002 Aug 27, 2002
  25. Levine JA, Jensen MD, Eberhardt NL, O'Brien T: Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest 101(8):1557-64, 1998
  26. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277(52):50230-6, 2002 https://doi.org/10.1074/jbc.M200958200
  27. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106(2):171-6, 2000
  28. Lehrke M, Lazar MA: Inflamed about obesity. Nat Med 10(2):126-7, 2004
  29. Rajala MW, Scherer PE: Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144(9):3765-73, 2003 https://doi.org/10.1210/en.2003-0580